Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05483270Completed
Randomised, open-label trial (2 arms), sponsored by Peking University Third Hospital. Primary endpoint: Live birth rate after the embryo transfer. Started Aug 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05483270.